|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Current assets: | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Short-term investments | |||||||||||||||||
| Restricted cash | |||||||||||||||||
| Accounts Receivable | |||||||||||||||||
| Inventories | |||||||||||||||||
| Receivable from noncontrolling interests | |||||||||||||||||
| Note receivable | |||||||||||||||||
| Lease receivable - current | |||||||||||||||||
| Deferred offering costs | |||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||
| Current assets of discontinued operations | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Property and equipment, net | |||||||||||||||||
| Natural gas properties, net | |||||||||||||||||
| Operating lease right-of-use assets, net | |||||||||||||||||
| Deferred tax assets | |||||||||||||||||
| Intangible assets | |||||||||||||||||
| Goodwill | |||||||||||||||||
| Lease receivable - noncurrent | |||||||||||||||||
| Restricted cash - noncurrent | |||||||||||||||||
| Equity method investments | |||||||||||||||||
| Other investments | |||||||||||||||||
| Other noncurrent assets | |||||||||||||||||
| Noncurrent assets of discontinued operations | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities and stockholders' equity | |||||||||||||||||
| Current liabilities: | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Accrued expenses | |||||||||||||||||
| Notes payable - current | |||||||||||||||||
| Debt - current | |||||||||||||||||
| Finance lease liabilities - current | |||||||||||||||||
| Operating lease liabilities - current | |||||||||||||||||
| Deferred revenue | |||||||||||||||||
| Due to related parties | |||||||||||||||||
| Other current liabilities | |||||||||||||||||
| Share liability | |||||||||||||||||
| Current liabilities of discontinued operations | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Deferred tax liabilities | |||||||||||||||||
| Convertible notes payable, at fair value | |||||||||||||||||
| Debt - noncurrent | |||||||||||||||||
| Finance lease liabilities - noncurrent | |||||||||||||||||
| Operating lease liabilities - noncurrent | |||||||||||||||||
| Deferred revenue - noncurrent | |||||||||||||||||
| Other noncurrent liabilities | |||||||||||||||||
| Noncurrent liabilities of discontinued operations | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Stockholders' equity | |||||||||||||||||
| Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2026 and December 31, 2025 | |||||||||||||||||
| Common stock, $0.01 par value; 500,000,000 shares authorized, 156,002,704 shares issued and 155,834,430 shares outstanding as of September 30, 2026 and 111,677,771 shares issued and outstanding as of December 31, 2025 | |||||||||||||||||
| Treasury stock at cost | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||||
| Total stockholders' equity attributed to ASP Isotopes Inc. stockholders | |||||||||||||||||
| Noncontrolling interests in consolidated subsidiaries | |||||||||||||||||
| Total stockholders' equity | |||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...